Article
Steady-State Therapy with Azithromycin or Low-Dose Prednisolone in Paediatric Cystic Fibrosis Patients: Inflammatory Markers and Disease Progression.
International archives of allergy and immunology - 1 Jan 2017
Shmarina Galina, Pukhalsky Alexander, Avakian Lucine, Semykin Sergey, Pukhalskaya Daria, Alioshkin Vladimir
Abstract excerpt
BACKGROUND: Anti-inflammatory therapy is a logical approach to slowing the inevitable lung function deterioration in cystic fibrosis (CF) patients. This study's aim was to evaluate inflammatory markers and disease progression in paediatric CF patients chronically treated with azithromycin or low-dose prednisolone. METHODS: The study included 204 patients with CF and 100 healthy controls; 102 CF patients were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
